More than a year after Johnson & Johnson won the last talcum powder verdict, trials involving ovarian cancer victims are gearing up again, with the first scheduled to start July 12.
Juries have awarded billions of dollars to women who got ovarian cancer, or their families, after decades of using baby powder and other talcum powder products made by Johnson & Johnson. Among those was a $4.7 billion jury award in 2018, later reduced to $2.1 billion. Johnson & Johnson, which has defended the safety of its products, has also lodged some victories, including the most recent trial in late 2019.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
